• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Novo Nordisk A/S

    Recent news which mentions Novo Nordisk A/S

    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
    Tags Breaking News: Investing Unilever PLC Novo Nordisk A/S
    From CNBC.com News
    Biden administration's Medicare drug price negotiations will face major tests in 2024
    Tags Health & Science Politics Pharmaceuticals
    From CNBC.com News
    Here are the big health sector themes to watch next year
    Tags Qiagen NV Health & Science Abbott Laboratories
    From CNBC.com News
    Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
    Tags Biogen Inc Biotechnology Novo Nordisk A/S
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags Politics US STEEL DRN Novo Nordisk A/S
    From CNBC.com News
    The weight loss drug boom isn't over yet — here's what to expect in the year ahead
    Tags Breaking news Amgen Inc Structure Therapeutics Inc
    From CNBC.com News
    Patients regain weight after stopping Eli Lilly's Zepbound, study says
    Tags Breaking news Business Health care industry
    From CNBC.com News
    Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
    Tags Companies US: News Eli Lilly and Co
    From CNBC.com News
    An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
    Tags Investment strategy Europe Markets Economy
    From CNBC.com News
    Cramer says the growing popularity of weight loss drugs brings new investing opportunities
    Tags Stock Picks Hormel Foods Corp Novo Nordisk A/S
    From CNBC.com News
    Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
    Tags Companies US: News Eli Lilly and Co
    From CNBC.com News
    Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
    Tags Diabetes Business Pfizer Inc
    From CNBC.com News
    Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
    Tags Business Biotech and Pharmaceuticals Health care industry
    From CNBC.com News
    Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
    Tags Biotech and Pharmaceuticals Health care industry Business News
    From CNBC.com News
    Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
    Tags stocks Investing Markets
    From CNBC.com News
    Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
    Tags US: News Companies Eli Lilly and Co
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags TJX Companies Inc Walmart Inc Investing
    From CNBC.com News
    Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
    Tags Health care industry Business News Business
    From CNBC.com News
    Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
    Tags Eli Lilly and Co Walmart Inc U/S/ Markets
    From CNBC.com News
    Cramer's Lightning Round: Buy AutoZone
    Tags Snowflake Inc/ Broadcom Inc U/S/ Markets
    From CNBC.com News
    FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
    Tags Biotech and Pharmaceuticals Health care industry Business News
    From CNBC.com News
    Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
    Tags US: News Companies Health & Science
    From CNBC.com News
    Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
    Tags Eli Lilly and Co US: News Companies
    From CNBC.com News
    Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
    Tags Business US: News Europe News
    From CNBC.com News
    Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
    Tags Breaking news Earnings Biotech and Pharmaceuticals
    From CNBC.com News
    Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
    Tags Spin/offs Pfizer Inc Business
    From CNBC.com News
    As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
    Tags Abbott Laboratories Weight management Novo Nordisk A/S
    From CNBC.com News
    CNBC Daily Open: Oil deals ahead of Big Tech earnings
    Tags Alphabet Inc Tesla Inc Banks
    From CNBC.com News
    CNBC Daily Open: Oil deals and awaiting tech earnings
    Tags Markets Chevron Corp Market Outlook
    From CNBC.com News
    Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
    Tags Health care industry Investing Eli Lilly and Co
    From CNBC.com News
    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.